Researchers examining mitochondrial signaling may also wish to review Klotho, a longevity-associated protein studied in related aging and metabolic contexts.
For the regulatory discussion specific to MOTS-c and other compounds considered by the FDA advisory panel, read FDA Advisory Panel Votes to Recommend BPC-157, TB-500, KPV, and MOTS-c for Compounding.
What Is MOTS-c?
MOTS-c (Mitochondrial-derived peptide c) is a 16-amino-acid peptide encoded within the 12S ribosomal RNA gene of the mitochondrial genome — a member of the mitochondrial-derived peptides (MDPs), a recently discovered class of mitochondria-encoded hormones. Discovered in 2015, MOTS-c acts as a mitochondria-to-nucleus retrograde signaling molecule that regulates nuclear gene expression in response to metabolic demand.
Mechanism of Action
MOTS-c translocates from mitochondria to the nucleus, where it regulates transcription of genes involved in metabolic adaptation — particularly those in the folate cycle and methionine metabolism pathways. It also activates AMPK (AMP-activated protein kinase) — the master metabolic regulator — contributing to enhanced insulin sensitivity, increased fatty acid oxidation, and reduced hepatic glucose production. These effects collectively mimic exercise adaptations at the molecular level.
Exercise Mimicry and Longevity
MOTS-c levels rise in response to exercise, and administration in aged or obese mice produces striking improvements: reversed insulin resistance, reduced fat accumulation, and dramatically enhanced exercise tolerance. MOTS-c levels decline with age, and genetic variants in the MOTS-c-encoding region of the mitochondrial genome correlate with longevity in multiple human population studies — making it one of the most promising aging biology research targets currently under investigation.
Quick Reference
Member reference tables summarize the compound's research parameters.
Research Indications
Research Protocols
As reported in cited literature and research-community logs (see Research Citations below), not a personal dosing recommendation.
This member section describes parameters reported in the research literature.
Peptide Interactions
This member section summarizes reported compound interactions and evidence limitations.
Reported Research Time Points
This member section summarizes reported research time points.
Safety Notes
Included for harm-reduction awareness only, in the event this compound is encountered outside its labeled research use. Inclusion here does not imply RUO Codes endorses, recommends, or instructs human use.
This member section discusses research safety considerations and uncertainties.
Quality Indicators
Research Citations
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
Lee, C., Zeng, J., Drew, B.G., et al., Cohen, P., 2015, Cell Metabolism - MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
Reynolds, J.C., Lai, R.W., Woodhead, J.S.T., et al., Lee, C., 2021, Nature Communications - The mitochondrial-encoded peptide MOTS-c translocates to the nucleus to regulate nuclear gene expression in response to metabolic stress
Kim, K.H., Son, J.M., Benayoun, B.A., Lee, C., 2018, Cell Metabolism - MOTS-c increases in skeletal muscle following long-term physical activity and improves acute exercise performance after a single dose
Hyatt, J.P., et al., 2022, Physiological Reports - The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitus
Yin, X., et al., 2022, Pharmacological Research - Downregulation of circulating MOTS-c levels in patients with coronary endothelial dysfunction
Qin, Q., Delrio, S., Wan, J., et al., Lerman, A., 2018, International Journal of Cardiology - Mitochondria-derived peptide MOTS-c: effects and mechanisms related to stress, metabolism and aging
Wan, W., Zhang, L., Lin, Y., et al., Ying, J., 2023, Journal of Translational Medicine - MOTS-c, the Most Recent Mitochondrial Derived Peptide in Human Aging and Age-Related Diseases
Mohtashami, Z., Singh, M.K., Salimiaghdam, N., et al., Kenney, M.C., 2022, International Journal of Molecular Sciences - MOTS-c Serum Concentration Positively Correlates with Lower-Body Muscle Strength and Is Not Related to Maximal Oxygen Uptake
Domin, R., Pytka, M., Żołyński, M., et al., Ruchała, M., 2023, International Journal of Molecular Sciences - Exploring the therapeutic potential of MOTS-c in age-related macular degeneration: from cellular responses to patient-derived cybrids
Mohtashami, Z., Schneider, K., Azimi, R., et al., Singh, M.K., 2025, Human Cell - MOTS-c is an effective target for treating cancer-induced bone pain through the induction of AMPK-mediated mitochondrial biogenesis
Yang, L., Li, M., Liu, Y., et al., Liu, S., 2024, Acta Biochimica et Biophysica Sinica